Notice of Intent to Publish a Funding Opportunity Announcement for NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33)

Opportunity ID: 291104 Opportunity Number: NOT-HL-16-475 Opportunity Title: Notice of Intent to Publish a Funding Opportunity Announcement for NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.839Eligible Applicants: State governments
County governments
City or township governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)Additional Information on Eligibility: Agency Code: HHS-NIH11Agency Name: Department of Health and Human Services
National Institutes of HealthPosted Date: Jan 06, 2017Last Updated Date: Apr 12, 2017Estimated Synopsis Post Date: Aug 10, 2017Fiscal Year: 2018Award Ceiling: $250,000Award Floor: Estimated Total Program Funding: $1,000,000Expected Number of Awards: 4Description: ​The National Heart, Lung, and Blood Institute intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applicationsfor investigator-initiated, phase 0 and I clinical trials (including bridging studies) for diagnosis and therapeutic interventions (e.g., drugs, devices, and biologics, including cells and cell products) for heart, lung, blood, and sleep (HLBS) disorders in adults and children.This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The FOA is expected to be published in Summer 2017 with a corresponding application due date in Fall 2017. This FOA will utilize the R61/R33 activity code. Details of the planned FOA are provided below.Version: Forecast 3 …read more

Posted in Business Tagged with: ,

40 travel companies ask Trump not to reinstate Cuba travel restrictions

The president has threatened to roll back trade agreements made by Barack Obama.

…read more

Posted in Personal Finance Tagged with:

MMA Biz: Conor McGregor’s Deal, Cyborg’s Assault, GSP’s Future, UFC Union Buzz, PPV Numbers And More

By Matt Connolly, Contributor Here are the five biggest developments in MMA Biz from the week-and-a-half gone by, featuring Conor McGregor, Georges St-Pierre, Cris “Cyborg” and more. …read more

Posted in Business Tagged with: ,

Bill Gates Gives Book Big Sales Bump After Recent Tweets To College Grads

By Russ Espinoza, Contributor Calling it “the most inspiring book I’ve ever read,” Gates’ recent endorsement of Steven Pinker’s ‘The Better Angels of Our Nature’ to the nation’s college graduates has elicited a 2,000 percent surge in paperback sales according to figures released by NBD Books on Wednesday. …read more

Posted in Management & Leadership Tagged with: ,

40 travel companies ask Trump not to reinstate Cuba travel restrictions

The president has threatened to roll back trade agreements made by Barack Obama.

…read more

Posted in Entrepreneurship Tagged with: ,

Merryn Somerset Webb on the social care U-turn

In this week’s FT Money show, columnist Merryn Somerset Webb tells presenter Claer Barrett why the government was wrong to u-turn on its manifesto pledge to change how social care is funded. Plus, what kinds of price reductions are buyers able to negotiate in the current property market, and how it’s possible to invest in stem cell research. …read more

Posted in Personal Finance Tagged with: